Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Patient Education and Counseling|January 10, 1998
Long-term effects and costs of brief behavioural dietary intervention for patients with diabetes delivered from the medical officeR E Glasgow, P A La Chance, D J Toobert, et al.Diabetes, Obesity & Metabolism|February 3, 2015
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)G B Bolli, M C Riddle, R M Bergenstal, et al.Diabetes, Obesity & Metabolism|April 8, 2015
One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extensionM C Riddle, H Yki-Järvinen, G B Bolli, et al.Diabetes, Obesity & Metabolism|June 5, 2015
Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetesM C Riddle, K C J Yuen, T W de Bruin, et al.Applied and Environmental Microbiology|July 1, 1996
A computer-simulated restriction fragment length polymorphism analysis of bacterial small-subunit rRNA genes: efficacy of selected tetrameric restriction enzymes for studies of microbial diversity in natureC L Moyer, J M Tiedje, F C Dobbs, et al.Diabetes & Metabolism|December 27, 2017
Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal eventsM C Riddle, G B Bolli, A Avogaro, et al.Diabetes, Obesity & Metabolism|July 15, 2015
Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extensionH Yki-Järvinen, R M Bergenstal, G B Bolli, et al.Diabetes, Obesity & Metabolism|June 25, 2014
Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetesP D Home, G B Bolli, C Mathieu, et al.Science (New York, N.Y.)|December 11, 1999
Microorganisms in the accreted ice of Lake Vostok, AntarcticaD M Karl, D F Bird, K Björkman, et al.The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated ApprovalM D Howe, K J Britton, H E Joyce, et al.Pageof 8